Neuropharma, Inc. — Form D

Neuropharma, Inc. of PARK CITY, UT, a company, filed a Form D exempt-offering notice with the SEC on 2020-12-04. The offering totals $5.2M, of which $2.1M was reported sold. Industry: Biotechnology.

Offering

• Filed: 2020-12-04
• Form: D
• Accession: 0001834263-20-000001
• Industry: Biotechnology
• Exemptions: 06b
• Total offering: $5.2M
• Amount sold: $2.1M
• Remaining: $3.2M
• Investors: 7
• Date of first sale: 2020-11-18
• Security types: equity
• Revenue range: Decline to Disclose
• SEC file number: 021-382261

Issuer

• Name: Neuropharma, Inc.
• CIK: 0001834263
• Entity type: Corporation
• Jurisdiction: DELAWARE
• Incorporated: 2020
• Address: 52 WHITE PINE CANYON RD., PARK CITY, UT, 84060
• Phone: (650) 464-9129

Officers, directors & promoters (2)

More

• CIK 1834263 on SEC EDGAR (source of record)
• This page as markdown (for LLM agents)
• Search all SEC filings, advisers and people on Adviser Search